Total Payments
$4,558
2024 Payments
$251.25
Companies
42
Transactions
135
Medicare Patients
1,861
Medicare Billing
$829,703
Payment Breakdown by Category
Food & Beverage$3,920 (86.0%)
Education$637.94 (14.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,920 | 128 | 86.0% |
| Education | $637.94 | 7 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $500.62 | 5 | $0 (2022) |
| Exelixis Inc. | $476.84 | 2 | $0 (2023) |
| Lilly USA, LLC | $309.22 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $280.99 | 6 | $0 (2023) |
| Genentech USA, Inc. | $269.99 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $250.62 | 15 | $0 (2024) |
| GENZYME CORPORATION | $213.11 | 6 | $0 (2023) |
| Incyte Corporation | $205.16 | 7 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $176.00 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $164.94 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.25 | 8 | Medtronic, Inc. ($115.38) |
| 2023 | $2,065 | 88 | Exelixis Inc. ($360.47) |
| 2022 | $646.01 | 15 | Lilly USA, LLC ($138.60) |
| 2021 | $688.89 | 12 | Lilly USA, LLC ($147.29) |
| 2020 | $177.48 | 3 | Janssen Biotech, Inc. ($99.00) |
| 2019 | $445.87 | 5 | Alexion Pharmaceuticals, Inc. ($176.00) |
| 2018 | $100.35 | 2 | E.R. Squibb & Sons, L.L.C. ($80.57) |
| 2017 | $183.39 | 2 | E.R. Squibb & Sons, L.L.C. ($183.39) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 3 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/28/2023 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Hematology | ||||||
| 08/25/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Oncology | ||||||
| 08/23/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $30.07 | General |
| Category: Hematology | ||||||
| 08/21/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Oncology | ||||||
| 08/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Genetic Disease | ||||||
| 07/28/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 07/26/2023 | Genentech USA, Inc. | Alecensa (Biological), Gavreto, Rozlytrek | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: BioOncology | ||||||
| 07/26/2023 | Genentech USA, Inc. | Alecensa (Biological), Gavreto, Rozlytrek | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: BioOncology | ||||||
| 07/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Oncology | ||||||
| 07/20/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/18/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 06/30/2023 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: BioOncology | ||||||
| 06/30/2023 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: BioOncology | ||||||
| 06/28/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Oncology | ||||||
| 06/21/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: HEMATOLOGY | ||||||
| 06/19/2023 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Hematology | ||||||
| 06/16/2023 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Hematology | ||||||
| 06/13/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: BioOncology | ||||||
| 05/31/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $54.40 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 1,681 | 64,867 | $1.6M | $802,675 |
| 2022 | 9 | 180 | 239 | $47,560 | $27,028 |
Total Patients
1,861
Total Services
65,106
Medicare Billing
$829,703
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 17 | 43 | $2,795 | $983.87 | 35.2% |
| J9190 | Injection, fluorouracil, 500 mg | Office | 2023 | 14 | 418 | $4,180 | $770.51 | 18.4% |
| J0640 | Injection, leucovorin calcium, per 50 mg | Office | 2023 | 11 | 200 | $2,000 | $619.39 | 31.0% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 17 | 29 | $1,450 | $616.83 | 42.5% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2023 | 11 | 10,200 | $5,100 | $575.68 | 11.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 27 | 44 | $2,200 | $455.40 | 20.7% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 15 | 21 | $1,050 | $424.62 | 40.4% |
| 96377 | Application of on-body injector for under skin injection | Office | 2023 | 12 | 28 | $1,400 | $411.88 | 29.4% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 11 | 3,300 | $3,300 | $391.50 | 11.9% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2023 | 30 | 990 | $4,950 | $299.02 | 6.0% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 18 | 54 | $270.00 | $105.40 | 39.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 34 | 930 | $1,860 | $90.82 | 4.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 21 | 53 | $530.00 | $60.65 | 11.4% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 20 | 47 | $94.00 | $36.52 | 38.9% |
| J3490 | Unclassified drugs | Office | 2023 | 14 | 37 | $182.00 | $23.70 | 13.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 34 | $9,350 | $5,448 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 41 | $7,175 | $4,249 | 59.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 50 | $7,500 | $4,130 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 27 | $6,075 | $3,966 | 65.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,000 | $2,737 | 54.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,660 | $2,172 | 59.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 33 | $3,300 | $1,898 | 57.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 11 | 11 | $3,300 | $1,222 | 37.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,200 | $1,207 | 54.9% |
About Dr. Laura Kohler, DO
Dr. Laura Kohler, DO is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679933956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Kohler, DO has received a total of $4,558 in payments from pharmaceutical and medical device companies, with $251.25 received in 2024. These payments were reported across 135 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,920).
As a Medicare-enrolled provider, Kohler has provided services to 1,861 Medicare beneficiaries, totaling 65,106 services with total Medicare billing of $829,703. Data is available for 2 years (2022–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Sterling Heights, MI
- Active Since 03/01/2016
- Last Updated 10/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679933956
Products in Payments
- CABOMETYX (Drug) $476.84
- ELIQUIS (Drug) $386.10
- JEVTANA (Drug) $270.34
- IMBRUVICA (Drug) $222.32
- SOLIRIS (Drug) $176.00
- Kadcyla (Biological) $156.94
- DUPIXENT (Biological) $130.02
- SIGNIA (Device) $115.38
- OPDIVO (Biological) $114.52
- BRUKINSA (Drug) $102.37
- VERZENIO (Drug) $92.63
- Nubeqa (Drug) $90.16
- KISQALI (Drug) $85.74
- JAKAFI (Drug) $71.59
- Stivarga (Drug) $70.34
- Doptelet (Drug) $59.19
- Lenvima (Drug) $58.38
- Blincyto (Biological) $54.82
- Epkinly (Drug) $54.40
- LONSURF (Drug) $52.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Internal Medicine $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Internal Medicine $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Internal Medicine $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Internal Medicine $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Internal Medicine $12,259
Dr. Nicolas Marsheh, M.d, M.D
Internal Medicine — Payments: $10,498
Internal Medicine $10,498